One-Size-Fits-All lactate test may miss risks in ICU patients

NCT ID NCT07582614

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This observational study of 16,000 ICU patients aims to find if age- and sex-specific blood lactate levels better predict death risk than the current standard threshold. Researchers will analyze hospital data from 2016-2024, focusing on sepsis patients. The goal is to improve early detection and personalized care for critically ill people.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could help doctors identify high-risk ICU patients earlier using personalized lactate thresholds, potentially reducing deaths from sepsis.

What could go wrong

This is an observational study using existing data, so it cannot prove cause and effect. The findings may not apply to all hospitals or patient groups.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEPSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

infectious disease with sepsis Sepsis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Uppsala University Hospital

    Uppsala, 75185, Sweden